Skip to content
The Policy VaultThe Policy Vault

Calquence (acalabrutinib) — Highmark

quantity limit exception

Initial criteria

  • additional quantities up to 4 tablets or capsules per day (100 mg) may be approved when the member is taking a strong CYP3A4 inducer

Approval duration

12 months